FONR RSI Chart
Last 7 days
-9.7%
Last 30 days
-7.7%
Last 90 days
-33.8%
Trailing 12 Months
-10.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 102.7M | 0 | 0 | 0 |
2023 | 97.7M | 98.6M | 101.3M | 102.4M |
2022 | 97.5M | 97.6M | 97.1M | 96.8M |
2021 | 86.0M | 89.9M | 92.7M | 96.0M |
2020 | 87.4M | 85.7M | 84.9M | 84.6M |
2019 | 85.7M | 87.2M | 88.2M | 88.5M |
2018 | 81.4M | 81.5M | 82.9M | 83.9M |
2017 | 75.9M | 78.0M | 78.6M | 80.4M |
2016 | 71.5M | 73.4M | 74.5M | 74.5M |
2015 | 69.2M | 69.1M | 68.7M | 70.0M |
2014 | 69.9M | 68.5M | 69.7M | 69.1M |
2013 | 40.1M | 49.1M | 56.5M | 64.5M |
2012 | 0 | 0 | 0 | 38.1M |
2011 | 0 | 0 | 0 | 0 |
2010 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Sep 30, 2022 | damadian timothy raymond | bought | 31,130 | 14.15 | 2,200 | ceo, president & treasurer |
Sep 30, 2022 | bonanni luciano b | bought | 48,144 | 14.16 | 3,400 | exec vp, coo & pfo |
Sep 29, 2022 | damadian timothy raymond | bought | 34,075 | 13.63 | 2,500 | ceo, president & treasurer |
Sep 29, 2022 | bonanni luciano b | bought | 17,966 | 13.82 | 1,300 | exec vp, coo & pfo |
Which funds bought or sold FONR recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | added | 67.87 | 207,825 | 457,254 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 113 | 556,710 | 974,336 | -% |
May 15, 2024 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | new | - | 398,000 | 398,000 | -% |
May 15, 2024 | RBF Capital, LLC | unchanged | - | 131,505 | 1,560,520 | 0.09% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | added | 5.95 | 232,682 | 1,715,040 | 0.04% |
May 15, 2024 | Royal Bank of Canada | added | 0.8 | 30,000 | 321,000 | -% |
May 15, 2024 | STATE STREET CORP | unchanged | - | 38,952 | 462,230 | -% |
May 15, 2024 | MORGAN STANLEY | added | 171 | 80,837 | 122,030 | -% |
May 15, 2024 | BARCLAYS PLC | sold off | -100 | -124,000 | - | -% |
May 15, 2024 | Polar Asset Management Partners Inc. | sold off | -100 | -580,932 | - | -% |
Unveiling FONAR Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to FONAR Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 196.9B | 23.7B | 44.73 | 8.29 | ||||
A | 45.2B | 6.7B | 36.57 | 6.71 | ||||
IDXX | 44.9B | 3.7B | 51.83 | 12.06 | ||||
DGX | 16.0B | 9.3B | 18.95 | 1.73 | ||||
NTRA | 13.1B | 1.2B | -35.76 | 10.81 | ||||
MEDP | 12.2B | 2.0B | 38.94 | 6.2 | ||||
CRL | 11.4B | 4.1B | 26.02 | 2.78 | ||||
EXAS | 9.3B | 2.5B | -38.69 | 3.67 | ||||
MID-CAP | ||||||||
GH | 3.1B | 603.7M | -6.73 | 5.14 | ||||
NEOG | 2.9B | 929.2M | 1.9K | 3.16 | ||||
SMALL-CAP | ||||||||
CDNA | 808.3M | 275.1M | -4.41 | 2.94 | ||||
ACRS | 84.8M | 31.1M | -1.1 | 2.73 | ||||
AWH | 33.0M | 9.2M | -2.24 | 3.6 | ||||
APDN | 2.5M | 5.5M | -0.2 | 0.45 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
FONAR Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 1.3% | 26.00 | 25.00 | 26.00 | 26.00 | 25.00 | 24.00 | 23.00 | 25.00 | 25.00 | 24.00 | 24.00 | 25.00 | 23.00 | 21.00 | 21.00 | 21.00 | 22.00 | 21.00 | 22.00 | 22.00 | 23.00 |
Costs and Expenses | 7.2% | 22.00 | 21.00 | 19.00 | 23.00 | 21.00 | 20.00 | 19.00 | 21.00 | 19.00 | 18.00 | 18.00 | 21.00 | 19.00 | 16.00 | 17.00 | 20.00 | 19.00 | 16.00 | 16.00 | 18.00 | 16.00 |
S&GA Expenses | 35.9% | 8.00 | 6.00 | 5.00 | 9.00 | 7.00 | 7.00 | 6.00 | 8.00 | 6.00 | 5.00 | 5.00 | 8.00 | 6.00 | 5.00 | 6.00 | 11.00 | 7.00 | 4.00 | 4.00 | 7.00 | 5.00 |
R&D Expenses | -0.5% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 |
EBITDA Margin | -1.1% | 0.20* | 0.20* | 0.23* | 0.20* | 0.22* | 0.23* | 0.25* | 0.28* | 0.28* | 0.27* | 0.26* | 0.24* | 0.21* | 0.20* | 0.20* | 0.21* | 0.25* | 0.29* | 0.30* | 0.30* | 0.31* |
Interest Expenses | -10.0% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Taxes | 35.3% | 2.00 | 1.00 | 2.00 | 1.00 | 0.00 | 1.00 | 1.00 | 0.00 | 2.00 | 1.00 | 1.00 | 2.00 | 0.00 | 1.00 | 1.00 | -0.40 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Earnings Before Taxes | -27.6% | 4.00 | 6.00 | 7.00 | 3.00 | 5.00 | 4.00 | 4.00 | 4.00 | 6.00 | 7.00 | 7.00 | 4.00 | 4.00 | 5.00 | 4.00 | 1.00 | 3.00 | 5.00 | 6.00 | 4.00 | 7.00 |
EBT Margin | -1.1% | 0.20* | 0.20* | 0.18* | 0.16* | 0.17* | 0.19* | 0.21* | 0.23* | 0.24* | 0.23* | 0.22* | 0.20* | 0.16* | 0.15* | 0.15* | 0.17* | 0.20* | 0.24* | 0.26* | 0.26* | 0.27* |
Net Income | -50.2% | 2.00 | 4.00 | 4.00 | 1.00 | 4.00 | 2.00 | 2.00 | 2.00 | 2.00 | 4.00 | 4.00 | 1.00 | 4.00 | 3.00 | 3.00 | 1.00 | 1.00 | 3.00 | 3.00 | 5.00 | 4.00 |
Net Income Margin | -15.6% | 0.11* | 0.13* | 0.11* | 0.10* | 0.11* | 0.09* | 0.11* | 0.13* | 0.11* | 0.13* | 0.13* | 0.11* | 0.12* | 0.09* | 0.09* | 0.10* | 0.14* | 0.17* | 0.17* | 0.18* | 0.24* |
Free Cashflow | -33.4% | 3.00 | 4.00 | 3.00 | 4.00 | 2.00 | 3.00 | 2.00 | 4.00 | 3.00 | 4.00 | 0.00 | 5.00 | 3.00 | 4.00 | 3.00 | 6.00 | 2.00 | 4.00 | 2.00 | 6.00 | -1.82 |
Balance Sheet | ||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q2 |
Assets | 3.6% | 210 | 202 | 202 | 201 | 199 | 197 | 198 | 199 | 196 | 194 | 188 | 190 | 187 | 185 | 183 | 180 | 134 |
Current Assets | 2.5% | 136 | 133 | 129 | 126 | 122 | 121 | 119 | 119 | 114 | 112 | 109 | 109 | 104 | 102 | 99.00 | 96.00 | 85.00 |
Cash Equivalents | 1.4% | 54.00 | 53.00 | 52.00 | 51.00 | 50.00 | 50.00 | 49.00 | 49.00 | 46.00 | 45.00 | 43.00 | 44.00 | 41.00 | 41.00 | 39.00 | 37.00 | 14.00 |
Net PPE | -4.3% | 19.00 | 20.00 | 21.00 | 22.00 | 23.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 21.00 | 21.00 | 17.00 |
Goodwill | 0% | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 0.00 | 4.00 | 4.00 | 4.00 | 4.00 |
Liabilities | 14.4% | 53.00 | 46.00 | 47.00 | 50.00 | 49.00 | 49.00 | 51.00 | 53.00 | 51.00 | 51.00 | 49.00 | 54.00 | 50.00 | 50.00 | 53.00 | 54.00 | 15.00 |
Current Liabilities | 2.3% | 15.00 | 14.00 | 14.00 | 16.00 | 14.00 | 14.00 | 15.00 | 17.00 | 14.00 | 14.00 | 16.00 | 20.00 | 17.00 | 17.00 | 19.00 | 19.00 | 14.00 |
Long Term Debt | -13.0% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 |
LT Debt, Current | 2.2% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 0.00 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -4.2% | 157 | 164 | 154 | 158 | 157 | 148 | 147 | 146 | 148 | 142 | 139 | 135 | 135 | 132 | 128 | 126 | 118 |
Retained Earnings | 11.5% | -14.45 | -16.33 | -20.08 | -24.19 | -25.43 | -29.29 | -31.52 | -33.57 | -35.81 | -38.10 | -42.12 | -46.01 | -46.73 | -50.60 | -53.71 | -56.22 | -64.46 |
Additional Paid-In Capital | 0% | 181 | 181 | 183 | 183 | 184 | 184 | 185 | 185 | 185 | 185 | 185 | 185 | 185 | 185 | 183 | 183 | 181 |
Shares Outstanding | -1.8% | 6.00 | 6.00 | 6.00 | - | 6.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
Minority Interest | -15.0% | -8.73 | -7.59 | -7.23 | -7.08 | -6.56 | -6.02 | -5.08 | -4.05 | -3.77 | -3.31 | -2.83 | -3.05 | -2.90 | -1.95 | -0.64 | 0.00 | 2.00 |
Float | - | - | - | - | - | - | 106 | - | - | - | 95.00 | - | - | - | 110 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -31.0% | 2,807 | 4,071 | 2,618 | 4,318 | 4,287 | 3,165 | 2,697 | 5,184 | 4,322 | 4,554 | 1,241 | 5,948 | 3,588 | 5,770 | 3,782 | 6,471 | 3,745 | 5,944 | 4,243 | 6,316 | 3,491 |
Cashflow From Investing | -117.3% | -289 | -133 | -79.00 | -698 | -2,204 | -473 | -963 | -766 | -1,723 | -1,481 | -1,209 | -646 | -1,940 | -1,798 | -435 | -960 | 13,300 | -2,349 | -2,568 | -421 | -15,874 |
Cashflow From Financing | 26.8% | -1,761 | -2,406 | -2,126 | -1,980 | -1,948 | -1,883 | -1,761 | -1,705 | -1,440 | -1,627 | -1,087 | -1,650 | -1,418 | -2,156 | -1,386 | 273 | -1,419 | -1,996 | -1,763 | -1,792 | -1,124 |
Buy Backs | -100.0% | - | 1,171 | 714 | 510 | 771 | 356 | 122 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | Mar. 31, 2024 | Mar. 31, 2023 | |
REVENUES | ||||
Patient fee revenue – net of contractual allowances and discounts | $ 8,614 | $ 8,188 | $ 25,511 | $ 21,393 |
Product sales – net | 110 | 25 | 329 | 225 |
Service and repair fees – net | 1,818 | 1,831 | 5,460 | 5,489 |
Service and repair fees - related parties – net | 39 | 28 | 94 | 83 |
Management and other fees – net | 12,149 | 12,375 | 36,585 | 36,717 |
Management and other fees - related medical practices – net | 2,988 | 2,975 | 8,962 | 8,962 |
Total Revenues – Net | 25,718 | 25,422 | 76,941 | 72,869 |
COSTS AND EXPENSES | ||||
Costs related to patient fee revenue | 4,437 | 4,056 | 13,466 | 11,879 |
Costs related to product sales | 153 | 196 | 558 | 580 |
Costs related to service and repair fees | 900 | 801 | 2,533 | 2,241 |
Costs related to service and repair fees - related parties | 82 | 12 | 106 | 34 |
Costs related to management and other fees | 6,864 | 7,157 | 21,095 | 20,281 |
Costs related to management and other fees – related medical practices | 1,529 | 1,455 | 4,638 | 4,345 |
Research and development | 414 | 435 | 1,297 | 1,126 |
Selling, general and administrative | 7,593 | 7,143 | 18,046 | 20,074 |
Total Costs and Expenses | 21,972 | 21,255 | 61,739 | 60,560 |
Income From Operations | 3,746 | 4,167 | 15,202 | 12,309 |
Other Income (Expense) | 45 | (6) | 46 | (203) |
Other Income – related party | (0) | 577 | 0 | |
Interest Expense | (9) | (15) | (67) | (41) |
Investment Income – related party | 13 | 0 | 13 | 0 |
Investment Income | 536 | 356 | 1,576 | 770 |
Income Before Provision for Income Taxes and Non controlling Interests | 4,331 | 4,502 | 17,347 | 12,835 |
Provision for Income Taxes | (1,848) | (17) | (4,884) | (2,889) |
Net Income | 2,483 | 4,485 | 12,463 | 9,946 |
Net Income – Non controlling Interests | (611) | (625) | (2,726) | (1,807) |
Net Income – Attributable to FONAR | $ 1,872 | $ 3,860 | $ 9,737 | $ 8,139 |
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands | Mar. 31, 2024 | Jun. 30, 2023 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 53,982 | $ 51,280 |
Short-term investments | 134 | 33 |
Accounts receivable – net | 3,309 | 3,861 |
Accounts receivable - related party | 30 | 0 |
Medical receivable – net | 23,583 | 21,259 |
Management and other fees receivable – net | 40,954 | 35,888 |
Management and other fees receivable – related medical practices – net | 9,590 | 9,162 |
Inventories | 2,935 | 2,570 |
Prepaid expenses and other current assets | 1,310 | 1,608 |
Total Current Assets | 135,827 | 125,661 |
Accounts receivable – long term | 576 | 710 |
Note receivable – related party | 590 | 0 |
Deferred income tax asset | 7,039 | 10,042 |
Property and equipment – net | 19,253 | 22,146 |
Right-of-use Asset – operating lease | 37,779 | 33,069 |
Right-of-use Asset – financing lease | 580 | 729 |
Goodwill | 4,269 | 4,269 |
Other intangible assets – net | 3,179 | 3,432 |
Other assets | 539 | 524 |
Total Assets | 209,631 | 200,582 |
Current Liabilities: | ||
Current portion of long-term debt | 46 | 44 |
Accounts payable | 1,676 | 1,579 |
Other current liabilities | 4,897 | 5,444 |
Unearned revenue on service contracts | 3,444 | 3,832 |
Unearned revenue on service contracts – related party | 28 | 0 |
Operating lease liability - current portion | 3,635 | 3,905 |
Financing lease liability - current portion | 224 | 218 |
Customer deposits | 553 | 602 |
Total Current Liabilities | 14,503 | 15,624 |
Long-Term Liabilities: | ||
Unearned revenue on service contracts | 572 | 760 |
Deferred income tax liability | 395 | 395 |
Due to related medical practices | 93 | 93 |
Operating lease liability – net of current portion | 36,466 | 32,105 |
Financing lease liability – net of current portion | 452 | 620 |
Long-term debt, less current portion | 80 | 115 |
Other liabilities | 40 | 42 |
Total Long-Term Liabilities | 38,098 | 34,130 |
Total Liabilities | 52,601 | 49,754 |
STOCKHOLDERS’ EQUITY: | ||
Paid-in capital in excess of par value | 180,607 | 182,613 |
Accumulated deficit | (14,454) | (24,191) |
Treasury stock, at cost - 4 shares of common stock at March 31, 2024 and 11 shares of common stock at June 30, 2023 | (395) | (516) |
Total Fonar Corporation’s Stockholders’ Equity | 165,759 | 157,907 |
Noncontrolling interests | (8,729) | (7,079) |
Total Stockholders’ Equity | 157,030 | 150,828 |
Total Liabilities and Stockholders’ Equity | 209,631 | 200,582 |
Class A Non Voting Preferred Stock [Member] | ||
STOCKHOLDERS’ EQUITY: | ||
Preferred stock value | 0 | 0 |
Preferred Stock [Member] | ||
STOCKHOLDERS’ EQUITY: | ||
Preferred stock value | 0 | 0 |
Common Stocks [Member] | ||
STOCKHOLDERS’ EQUITY: | ||
Common stock value | 1 | 1 |
Common Class B [Member] | ||
STOCKHOLDERS’ EQUITY: | ||
Common stock value | 0 | 0 |
Common Class C [Member] | ||
STOCKHOLDERS’ EQUITY: | ||
Common stock value | $ 0 | $ 0 |